Results 1 to 10 of about 27,323 (239)

Can We Improve Antifungal Susceptibility Testing? [PDF]

Frontiers in Cellular and Infection Microbiology, 2021
Systemic antifungal agents are increasingly used for prevention or treatment of invasive fungal infections, whose prognosis remains poor. At the same time, emergence of resistant or even multi-resistant strains is of concern as the antifungal arsenal is ...
Charlotte Durand, Danièle Maubon, Danièle Maubon, Muriel Cornet, Muriel Cornet, Yan Wang, Delphine Aldebert, Cécile Garnaud, Cécile Garnaud   +8 more
doaj   +2 more sources

Antifungal Susceptibility Testing Experience in the Management of Culture-Positive Mucormycosis: Observation from a Large Healthcare System [PDF]

Journal of Fungi
Background: Mucormycosis, an invasive fungal infection with high morbidity and mortality rates, requires prompt surgical and antifungal therapies; however, the role of antifungal susceptibility testing (AFST) in clinical management of mucormycosis ...
Maryam Naveed, Tirdad T. Zangeneh, Nathan P. Wiederhold, William Lainhart, Mohanad M. Al-Obaidi   +4 more
doaj   +2 more sources

Impact of the Disk Diffusion Test on Fluconazole De-Escalation in Patients with Candidemia

Journal of Fungi, 2022
Disk diffusion (DD) is a simple antifungal susceptibility method for Candida. This study examined the impact of fluconazole DD testing on antifungal de-escalation.
Suchavadee Tantasuwan, Piriyaporn Chongtrakool, Amiroh Waesamaae, Methee Chayakulkeeree   +3 more
doaj   +1 more source

Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris

Microbiology Spectrum, 2021
Candida auris is an emerging yeast pathogen of candidemia with the ability to develop resistance to all current antifungal drug classes. Novel antifungal therapies against C. auris are warranted. NSC319726 is a thiosemicarbazone with an inhibitory effect
Jizhou Li, Alix T. Coste, Daniel Bachmann, Dominique Sanglard, Frederic Lamoth   +4 more
doaj   +1 more source

Antifungal susceptibility testing for yeasts: how, when and why, according to the new EUCAST guidelines

Microbiologia Medica, 2011
Antifungal susceptibility testing of yeasts and the development of interpretive breakpoints are nowadays very important topics both for the increasing incidence of invasive mycoses and number of available antifungal drugs and for the appearance of ...
Esther Manso, Claudio Farina, Stefano Andreoni, Marco Conte, Paolo Fazii, Gianluigi Lombardi, Silvana Sanna   +6 more
doaj   +1 more source

A study of dermatophytosis in patients attending dermatology outdoor patient department at a tertiary care center

Indian Journal of Health Sciences and Biomedical Research KLEU, 2023
BACKGROUND AND PURPOSE: Dermatophytosis is a superficial fungal infection of keratinized tissue caused by dermatophytes. The dermatophytes are included in three fungal genera: Epidermophyton, Microsporum, and Trichophyton.
Vaibhavi Vijay Nanoty, Priyanka Kishanbhai Patel, Rajesh Mahadeo Trimukhe, Milind Ramchandra Ubale, Debapriya Das Choudhury, Pradnya R Joshi   +5 more
doaj   +1 more source

Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method

Indian Journal of Pathology and Microbiology, 2014
With the increase in invasive fungal infections due to Candida species and resistance to antifungal therapy, in vitro antifungal susceptibility testing is becoming an important part of clinical microbiology laboratories.
Sidhartha Giri, Anupma Jyoti Kindo
doaj   +1 more source

ASSESSMENT OF SPECIATION AND ANTIFUNGAL SUSCEPTIBILITY TESTING IN THE INTENSIVE CARE UNIT: AN OBSERVATIONAL CROSS-SECTIONAL STUDY DESIGN.

Student's Journal of Health Research Africa, 2023
Objectives:  This study aims to investigate the epidemiology of Candidemia in patients admitted to Intensive Care Units (ICUs), focusing on the distribution of species, antifungal susceptibility patterns, and demographic factors.
Bhuvan Shome, Ashok Kumar Sharma, Kumari Seema, Abhay Kumar, Manoj Kumar, Manju Boipai   +5 more
doaj   +1 more source

Fungal Profile and Its Characteristics in Patients Section of Otomycosis-A Prospective Study [PDF]

National Journal of Laboratory Medicine, 2019
Introduction: Fungal ear infection is one of the most common infections, which is termed as otomycosis. Common causative agents are Aspergillus and Candida species.
Sushil Kumar Aggarwal, Kirti Jaiswal
doaj   +1 more source

A case of Candida famata sepsis in a very low birth weight infant successfully treated with fluconazole following antifungal susceptibility testing

Medical Journal of Dr. D.Y. Patil University, 2015
Late onset of fungal sepsis in very low birth weight (VLBW) infants is common and has a high mortality and morbidity. Many of these infants were also receiving fluconazole prophylaxis.
Shilpee Raturi, Suresh Chandran, Roopa Viswanathan   +2 more
doaj   +1 more source